Why? Because they know and have told us the clinical trials are going as expected and only need another quarter as insurance. They will do a CR at higher price mid this year which I've been telling you guys and will buy back the CN with the $20M 2024 R&D rebate.
IMU Price at posting:
3.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)